https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-03-07 / Cancer Immunol Immunother 2023 Mar;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-03-07 / Cancer Immunol Immunother 2023 Mar;2023-03-07 00:00:002023-03-07 00:00:00A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-03-02 / NPJ Vaccines 2023 Mar;8(1):29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-03-02 / NPJ Vaccines 2023 Mar;8(1):292023-03-02 00:00:002023-05-30 16:16:10Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-22 / Cancers (Basel) 2023 Feb;15(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-22 / Cancers (Basel) 2023 Feb;15(5)2023-02-22 00:00:002023-02-22 00:00:00From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-200
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-2002023-02-17 00:00:002023-02-17 00:00:00Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-16 / Biochem Biophys Res Commun 2023 Apr;653:106-114
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-16 / Biochem Biophys Res Commun 2023 Apr;653:106-1142023-02-16 00:00:002023-02-16 00:00:00Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-13 / NPJ Breast Cancer 2023 Feb;9(1):7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-13 / NPJ Breast Cancer 2023 Feb;9(1):72023-02-13 00:00:002023-02-13 00:00:00Immunotherapy in breast cancer: an overview of current strategies and perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-13 / Cancers (Basel) 2023 Feb;15(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-13 / Cancers (Basel) 2023 Feb;15(4)2023-02-13 00:00:002023-05-30 16:20:40Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-01 / J Med Virol 2023 Feb;95(2):e28554
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-01 / J Med Virol 2023 Feb;95(2):e285542023-02-01 00:00:002025-09-06 13:30:27Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-31 / Expert Opin Drug Discov 2023 Jan;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-31 / Expert Opin Drug Discov 2023 Jan;2023-01-31 00:00:002023-01-31 00:00:00Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022
https://www.iozk.de/wp-content/uploads/2020/11/IOZK_team_van-gool_175828-ret.jpg
518
690
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2023-01-23 16:08:352023-01-25 16:42:45Stefaan van Gool ist Herausgeber einer Sonderausgabe im Journal of Molecular Sciences
